International Paper CEO Andy Silvernail said the Georgetown SC mill closure is part of a broader strategy to combat ...

BOSTON -- It took 16 years, but the Celtics officially raised banner No. 18 to the TD Garden rafters Tuesday night, as the franchise celebrated its record-setting 18th NBA championship ahead of ...

What is the current and next Honkai Star Rail banner? If you want to pick up the best five-star characters for your team, then wishing on banners is your best bet. HSR banners rotate regularly ...

The Boston Celtics lifted their 18th championship banner to the TD Garden rafters on Tuesday night. Unfortunately, the only Celtics fans who were able to watch Boston’s latest banner raising ...

One of Memphis' largest employers plans to lay off hundreds of workers. International Paper will lay off 650 employees company-wide, with 400 of those in Memphis — about 19% of its workforce here.

Before the game, the Huskies unveiled their 2023-24 national championship banner. UConn had four starters taken in the NBA draft last summer. Stephon Castle, Donovan Clingan, Tristen Newton and Cam ...

Despite its success, Wuthering Waves is facing some criticism, with players divided on whether rerun banners benefit the game’s long-term health. Kuro Games initially launched the ARPG with 18 ...

BOSTON -- The rafters in TD Garden got a little more crowded on Tuesday night, as the Celtics raised the franchise's 18th championship banner to close the book on their 2023-24 NBA title.

BOSTON — For those who dig symbolism, let it be known that the raising of the Boston Celtics’ 18th championship banner Tuesday night began its ascent to the TD Garden rafters directly in front ...

OnKure is currently developing OKI-219, a selective PI3Kα H1047R inhibitor, as its lead program. OnKure aims to become a leader in targeting oncogenic PI3Kα and has multiple programs designed to ...

OKI-219 is being investigated in the PIKture-01 clinical trial. PIKture-01 is a first-in-human study of the PI3KaH1047R Mutant-Selective Inhibitor OKI-219 as monotherapy in participants with advanced ...